ADRB2 and cancer: Blockade of β2-AR and NGF/Trk pathways decreased cancer incidence and extended the survival of KPC (LSL-Kras+/G12D;LSL-Trp53+/R172H;Pdx1-Cre) mice, directly linking chronic stress to PDAC development via a β-AR/neurotrophinloop [82].